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The main functional goals of human ambulation are to move safely and efficiently from one place to another. Normal locomotion is related to selective muscle control and normal range of motion of the joints. Inadequate motor control and limb deformities are common consequences of the upper motoneuron syndrome (UMNS). Spasticity is one of the components of UMNS; it is characterized by a velocity-dependent increase in muscle tone, resulting from hyperexcitability of the stretch reflex. Other components include weakness and loss of dexterity. 1 Hip adductor muscle overactivity is one of the consequences of lower limb involvement in UMNS. Hygiene, dressing, sexual intimacy, sitting, transfers, standing, and walking can be compromised in patients with hip adductor spasticity. 2 Gait analysis of patients with hip adductor spasticity has demonstrated a narrow base of support, poor standing balance, and unstable gait. [3] [4] [5] Although there are several different definitions for the base of support, in our laboratory, we use the measurement of the perpendicular distance between the most medial point of the inner border of each foot or, when shoes are worn, the most medial edge of the shoes (Fig. 1 ). Walking base of support is normally in the range of 50 -100 mm. 6 A narrow base of support may result in instability of the whole body; for this reason, correction of the problem is important, even for limited ambulation. Hip adductor muscle overactivity and reverse circumduction during the swing phase are the most common causes of a narrow base of support in patients with UMNS. Interventions for a narrow base of support problem may include phenol neurolysis to the obturator nerve, motor point blocks of the hyperactive musculature with phenol, or botulinum toxin injected directly into the hip adductor muscles. 7, 8 Phenol solutions of 5-7% are most commonly used to produce chemical neurolysis. 3, 9, 10 The aim of this study was to evaluate selected temporospatial parameters of locomotion (base of support, step length, and velocity of gait) both before and after obturator nerve block with 7% aqueous phenol solution in patients with unilateral hip adductor muscle overactivity with scissoring gait.
MATERIALS AND METHODS
In this retrospective study, 24 patients' files were selected from the records of the Gait and Motion Analysis Laboratory, Philadelphia, PA. Selected files were for patients referred for gait analysis between March 1997 and August 2002 because of walking difficulties produced by a narrow base of support and who underwent unilateral obturator nerve block with phenol. Presenting problems included adductor overactivity in one lower limb produced by traumatic brain injury, stroke, spinal cord injury, cerebral palsy, or multiple sclerosis.
Gait Analysis. Temporospatial parameters of gait, such as base of support, step length, and walking veloc-ity, were assessed in this study. The electronic gait mat (Gait Mat II), originally designed in the Rehabilitation Engineering Center based at MossRehab, is routinely used to measure temporospatial gait parameters. Measuring 3.8 m in length, the mat contains approximately 10,000 electronic switches, scanned at 100 Hz, that record foot contact and generate a left and right "electronic footprint." Patients are not otherwise instrumented, and data collection simply requires subjects to walk across the mat. They may use gait aids or shoes and braces if necessary. Using a personal computer, data are calculated and a printout is generated. The results include walking velocity, stride time, cadence, stance and swing times, double-support times, step lengths, step times, and measurement of the base of support.
Patients who were able to walk with or without the use of upper limb walking aids and with or without a brace were studied. Patients were asked to walk on the electronic Gait Mat II at a self-selected walking velocity before obturator nerve block and 15 min after the injection of phenol into the obturator nerve. They walked across the Gait Mat II several times to obtain at least ten strides of steady-state walking. Walking velocity, step length, and base of support were the temporospatial variables of gait that were analyzed. We hypothesized that only base of support and possibly step length would change as a result of the block. Velocity was analyzed because temporospatial parameters vary as a function of this parameter. These three temporospatial parameters were studied, and the other temporospatial data were collected but not included in the analysis.
Procedure. After temporospatial parameters were obtained with the electronic Gait Mat II, consent was obtained from the patient, and he or she was placed in the supine position. The leg was abducted as much as anatomically feasible to make the hip adductor longus tendon prominent below the symphysis pubis. The injection site was localized 1 cm distal and lateral to the pubic tubercle over the adductor longus tendon. A 22-gauge, 75-mm-long, Teflon-coated, open-lumen needle electrode connected to an electrical stimulator was used for the block. A reference electrode was placed under the ipsilateral gluteal area. After appropriate skin preparation and under aseptic conditions, the needle was inserted and directed rostrally, posteriorly, and laterally to touch the pubis or its superior ramus. The needle was withdrawn and redirected laterally to slip under the lower border of the superior ramus of the pubis and into the obturator foramen. The nerve was stimulated through the needle electrode initially with a square pulse of approximately 1.5 mA once per second. When a visible and or palpable muscle twitch of the hip adductors was apparent, the current was gradually decreased to a level of about 0.5 mA. If a response was evident at this level of stimulation, 3-5 ml of 7% phenol in sterile water solution were injected through the needle electrode.
During the injection, brief discomfort was the most common complaint. No other adverse effects or postblock complications were reported immediately; in addition, patients did not report complaints of pain at their subsequent follow-up appointment.
RESULTS
A total of 24 patients' files were selected for this study. The patients' mean age was 48.1 Ϯ 20.7 yr (range, 21-85 yr); 75% of patients (n ϭ 18) were men. Etiologic diagnoses included traumatic brain injury (12 patients), incomplete spinal cord injury (four patients), cerebral palsy (two patients), cerebrovascular accident (three patients), and multiple sclero-sis (one patient). The injections were done on the right side in 41.7% of patients (n ϭ 10) ( Table 1) .
Statistical analysis of the data was done utilizing a nonparametric Wilcoxon's signed-rank test to compare preinjection with postinjection results. Before injection, the average walking velocity, step length, and base of support were 0.42 Ϯ 0.34 m/sec, 0.37 Ϯ 0.15 m, and 0.065 Ϯ 0.045 m, respectively. After phenol injection to the obturator nerve, the average walking velocity, step length, and base of support values were 0.41 Ϯ 0.33 m/sec, 0.36 Ϯ 0.15 m, and 0.076 Ϯ 0.045 m, respectively. The statistical analysis showed no difference in the postinjection walking velocity and step length value. However, the postinjection base of support value was significantly increased (P ϭ 0.03) ( Table 2 ).
DISCUSSION
The most important issue for spasticity management is the selection of an ideal treatment intervention. When spasticity has been appropriately treated, a reduction of the reflexive contractions of muscle without affecting voluntary control is expected. Local blocks of specific muscle with botulinum toxin, phenol motor points, or nerve blocks with phenol seem to be the most useful techniques in the management of focal limb spasticity. 11 Chemical neurolysis has been widely used to treat muscle overactivity for many years. The most frequently used agents are botulinum toxin and phenol. Phenol impedes the conduction through a portion of the nerve with interruption of the stretch reflex arc in spastic muscles. This beneficial effect is achieved without the undesirable side effects of systemic oral agents. Chemical neurolysis has been performed at every anatomic level of the peripheral nervous system from the root to the motor end plate. 12 In this retrospective study, the medical records of patients with UMNS evaluated in the Gait Laboratory were reviewed. We analyzed data from 24 subjects with narrow base of support who underwent percutaneous unilateral obturator nerve blockade with 7% phenol solutions to reduce hip adductor muscles overactivity and narrow base of support. The results showed that the base of support value increased significantly (P ϭ 0.03), although walking velocity and step length did not change.
Several studies have shown that muscle spasticity decreased after alcohol or phenol nerve blocks or neuromuscular injection with botulinum toxin A. [13] [14] [15] [16] However, only a few studies showed that abnormal gait pattern improved after phenol obturator nerve block. 14, 15 Wassef 15 performed obturator nerve block with 6% phenol solutions in patients who had hip adductor spasticity, using both interadductor and traditional obturator nerve approaches. Muscle spasm, hygiene, gait score, and patient satisfaction was assessed by global assessment. A 60% success rate was found in all parameters for the blocks using both techniques. In another study, obturator nerve block with ethanol decreased severe adductor spasticity and improved patients' gait pattern and hygiene. However, Viel et al. 14 used the Global Assessment Scoring System to evaluate the walking capacity of the patients involved in this study; quantitative data were not obtained.
Different concentrations of phenol solutions can be used for spasticity management. Concentrations of Ͻ3% phenol solution require frequent repetition of the block. Concentrations of 5% phenol produce greater effect but may cause tissue necrosis. 11 Concentrations of 7% are the highest possible before solution precipitation occurs. The duration of the effects of phenol injection may be influenced by many factors, most importantly, precision of the injection and concentration and volume of the phenol solution. Duration of functional improvement after phenol injection ranges from 1 to 10 mo. 17 UMNS involving the lower limbs can interfere with activities of daily living, mobility, and communication. The patient with UMNS may present with common abnormal movement patterns and gait deviations. We have described seven patterns of upper motor neuron dysfunction in the lower limb that interfere with gait: equinovarus foot, toe curling, stiff knee, adducted (scissoring) thighs, flexed knee, flexed hip, and hyperextended great toe. 2, 3 These abnormalities can be seen alone or in combination, and they disturb the gait pattern. 18 Clinical gait analysis has an important role to play in assessing lower limb spasticity. 19 Motor control evaluation in the gait laboratory is not only intended to identify and understand the problems caused by gait deviations, but it also helps to plan their management. Clinical observation alone is incapable of clearly elucidating the problem; objective data are needed for the assessment of the gait and the measurement of treatment outcomes. Combining clinical evaluation with laboratory assessments will increase the degree of information resolution needed to understand the common patterns of gait dysfunction in UMNS. 5 Many methods of gait analysis are used clinically, including observational methods (with and without video), kinematic methods (measures of stride and joint motion), kinetic analysis, energetics (metabolic energy consumption), and dynamic electromyographic methods. Observational gait analysis, with or without video recording, is clinically feasible, inexpensive, and an adequate procedure for documenting some features of gait; the lack of quantitative data and the need to rely on observers to describe gait can make it unreliable when comparing findings with previous data or other subjects. Kinematics, kinetics, dynamic electromyography, and energetics require the use of special equipment, such as electrogoniometers, three-dimensional motion analysis systems, polyelectromyographic instrumentation, force platforms, and oxygen-consumption equipment. These systems can measure precisely and quantitatively, but they require patient cooperation, they are time consuming, and they have a higher cost.
Measurement of temporal and spatial parameters of walking is relatively simple and useful with technology that requires no or minimal subject instrumentation. A number of techniques have been used to analyze temporospatial variables, including the use of ink and paper, foot switches, and other more sophisticated motion analysis systems. The electronic Gait Mat II system was used in this study for its simplicity, reliability, and repeatability. 20 Hip adductors overactivity is characterized by adduction of the hip during the swing phase of locomotion, resulting in a narrow base of support in stance phase, with potential impairment of balance. 5 Adductor spasticity with scissoring thighs may also lead to impaired limb advancement and clearance. In our study, we measured three temporospatial variables of gait (walking velocity, step length, and base of support) in patients with hip adduction secondary to UMNS. After injection, the width of the base of support was significantly increased, although there was no statistical change in walking velocity and step length. This is a retrospective study that used each subject as his or her own control. Data were obtained within 15 min after block. It is possible that greater gains would have been observed at a later time as a result of the full effects of the phenol injection. The usual implementation of rehabilitation interventions after block, including stretching, strengthening, and gait retraining to address muscle weakness, might result in an increase in walking velocity and step length and in an increased gain at the base of support
In conclusion, this study demonstrated that obturator neurolysis with a 7% phenol solution was an effective procedure to decrease hip adductor muscle overactivity, without any complications or adverse reactions, and resulting improvement in the base of support of patients with UMNS. Increase in the base of support may result in an improvement in dynamic stability during ambulation. This study illustrates the potential for global clinical improvement after interventions to address a focal problem.
